Evidence map›Paper›PMID 23575660›Full record

ReviewChemical Society reviews2013

Manipulating biological agents and cells in micro-scale volumes for applications in medicine.

Savas Tasoglu, Umut Atakan Gurkan, Shuqi Wang, Utkan Demirci

Registry-linked trialAbstract readReview
In one paragraph

Review in Chemical Society reviews, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02824471 (Sickle Cell Disease), which is not on this map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02824471 recruitingnot on this mapstarted 2014, after this paper: background citation

Sickle Cell Disease (SCD) Biochip': Towards a Simple and Reliable Way to Monitor Sickle Cell Disease

TypeobservationalSponsorUniversity Hospitals Cleveland Medical CenterRan2014 to 2028Enrolled100ConditionsSickle Cell DiseaseArmsSCD Group
3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Article
  2. Review
  3. Advances of medical nanorobots for future cancer treatments.Journal of hematology & oncology · 2023
    Review
  4. Review
  5. Article
  6. Magnetic Microrobots Fabricated by Photopolymerization and Assembly.Cyborg and bionic systems (Washington, D.C.) · 2023
    Article
  7. Review
  8. Article
  9. Reversible Design of Dynamic Assemblies at Small Scales.Advanced intelligent systems (Weinheim an der Bergstrasse, Germany) · 2021
    Article
  10. Reconfigurable multifunctional ferrofluid droplet robots.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  11. Medical Micro/Nanorobots in Precision Medicine.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Review
  12. Article
  13. 3D Bioprinting Stem Cell Derived Tissues.Cellular and molecular bioengineering · 2018
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Savas TasogluBio-Acoustic-MEMS in Medicine (BAMM) Laboratory, Division of Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Umut Atakan Gurkan
Shuqi Wang
Utkan Demirci

Funding

Rapid Fluorescence-Based Determination of Antibiotic SusceptibilityU54EB015408 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI PARRISH, JOHN A, SCHACHTER, STEVEN · 2012 to 2022
$49.2M
Point-of-Care Rapid Blood Testing Using Microfluidic DevicesR01AI081534 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI DEMIRCI, UTKAN · 2009 to 2013
$2.1M
Novel disposable microchips for HIV-1 viral loadR01AI093282 · NIAID · STANFORD UNIVERSITY · PI DEMIRCI, UTKAN · 2012 to 2015
$1.7M
Minimizing the role of cryoprotectant toxicity for cryopreservationR01EB015776 · NIBIB · STANFORD UNIVERSITY · PI DEMIRCI, UTKAN · 2012 to 2015
$1.5M
Microfluidic Chip for Cryopreservation of Blood CellsR21HL095960 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI DEMIRCI, UTKAN · 2011 to 2012
$491k
Antibody-based cell purification at resource limited setting for HIVR21AI087107 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI DEMIRCI, UTKAN · 2010 to 2011
$488k
Nano-Acoustic Masonry of Microgels for Bottom-Up Tissue EngineeringR21HL112114 · NHLBI · PENNSYLVANIA STATE UNIVERSITY, THE · PI DEMIRCI, UTKAN, DEMIREL, MELIK · 2012 to 2013
$452k
NHLBI NIH HHS R21 HL095960NHLBI NIH HHS R21 HL112114NIAID NIH HHS R01 AI081534NIAID NIH HHS R01 AI093282NIAID NIH HHS R21 AI087107NIBIB NIH HHS R01 EB015776NIBIB NIH HHS U54 EB015408
6 · The paper itself

Abstract

Recent technological advances provide new tools to manipulate cells and biological agents in micro/nano-liter volumes. With precise control over small volumes, the cell microenvironment and other biological agents can be bioengineered; interactions between cells and external stimuli can be monitored; and the fundamental mechanisms such as cancer metastasis and stem cell differentiation can be elucidated. Technological advances based on the principles of electrical, magnetic, chemical, optical, acoustic, and mechanical forces lead to novel applications in point-of-care diagnostics, regenerative medicine, in vitro drug testing, cryopreservation, and cell isolation/purification. In this review, we first focus on the underlying mechanisms of emerging examples for cell manipulation in small volumes targeting applications such as tissue engineering. Then, we illustrate how these mechanisms impact the aforementioned biomedical applications, discuss the associated challenges, and provide perspectives for further development.

Indexed as

Models, BiologicalAnimalsBioengineeringBioprintingHumansMicrofluidic Analytical TechniquesNanomedicine

Identifiers

PMID23575660
PMCPMC3865707

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.